# Inmune Bio, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:a0f62a80-958f-46ca-b155-b220e0af379f |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/inmune-bio-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 21 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-21T04:47:00.160454+00:00 |
| Last reviewed | 2026-10-21T04:47:00.160454+00:00 |

## Identity

- Legal name: Inmune Bio, Inc.
- Display name: Inmune Bio, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-21T09:39:51.457135+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.835 |
| Directors | 5 |
| Committees | 6 |
| Governance events | 14 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- David J. Moss: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:5
- J. Kelly Ganjei: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:6
- Marcia Allen: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:7
- Scott Juda, J.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:8
- Timothy Schroeder: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:9

## Committees

- Audit (audit). Chair: NOT_PUBLISHED. Members: Marcia Allen (member, current); Timothy Schroeder (member, current). committee_id=alpha:committee:inmune-bio-inc:audit
- Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Timothy Schroeder (member, current). committee_id=alpha:committee:inmune-bio-inc:audit-compensation-chair
- Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Marcia Allen (member, current). committee_id=alpha:committee:inmune-bio-inc:audit-nominating-and-governance-chair
- Compensation (compensation). Chair: Timothy Schroeder. Members: Timothy Schroeder (chair, current); J. Kelly Ganjei (member, current). committee_id=alpha:committee:inmune-bio-inc:compensation
- Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: J. Kelly Ganjei (member, current). committee_id=alpha:committee:inmune-bio-inc:compensation-nominating-and-governance
- Nominating and Governance (nominating_governance). Chair: Marcia Allen. Members: Marcia Allen (chair, current); J. Kelly Ganjei (member, current). committee_id=alpha:committee:inmune-bio-inc:nominating-and-governance

## Executive leadership

- Cory Ellspermann: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:10
- David J. Moss: President, CEO, Secretary, Treasurer and Director [CEO]. Status: current. claim_id=alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:11
- Mark Lowdell, PhD: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:12

## Governance events

- CFO_CHANGED: Cory Ellspermann executive of Inmune Bio, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:1ajhrmkcsd460
- CEO_CHANGED: David J. Moss executive of Inmune Bio, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:78zn671d5s5w5
- EXECUTIVE_APPOINTED: Mark Lowdell, PhD executive of Inmune Bio, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:3yf50z46orzr
- DIRECTOR_APPOINTED: David J. Moss seat on Inmune Bio, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:1b3l5lzcz8eet
- DIRECTOR_APPOINTED: Marcia Allen seat on Inmune Bio, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:14qx7eg1r3wjfg
- COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Inmune Bio, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:1hhlhlik5egz4
- COMMITTEE_MEMBER_ADDED: Marcia Allen member of Audit; Nominating and Governance · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:ekqz71da9u1b
- DIRECTOR_APPOINTED: Scott Juda, J.D. seat on Inmune Bio, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:1pwzq9gsm2t3i
- DIRECTOR_APPOINTED: J. Kelly Ganjei seat on Inmune Bio, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:1bhj79418zl1ce
- DIRECTOR_APPOINTED: Timothy Schroeder seat on Inmune Bio, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:bno62l6ot6h1
- COMMITTEE_CREATED: Audit; Compensation · Chair committee of Inmune Bio, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:1bs17qt1krn06d
- COMMITTEE_MEMBER_ADDED: Timothy Schroeder member of Audit; Compensation · Chair, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:1g47pjvrbth9
- COMMITTEE_CREATED: Compensation; Nominating and Governance committee of Inmune Bio, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:1836i1qokq87m
- COMMITTEE_MEMBER_ADDED: J. Kelly Ganjei member of Compensation; Nominating and Governance, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:00.160454+00:00. event_id=alpha:event:transition:1x25f6qanc2dk

## Scoped resources

- `alpha://company/inmune-bio-inc` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record
- `alpha://company/inmune-bio-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=identity
- `alpha://company/inmune-bio-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=corporate-structure
- `alpha://company/inmune-bio-inc/board` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=board
- `alpha://company/inmune-bio-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=committees
- `alpha://company/inmune-bio-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=leadership
- `alpha://company/inmune-bio-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=ownership
- `alpha://company/inmune-bio-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=financials
- `alpha://company/inmune-bio-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=capital-structure
- `alpha://company/inmune-bio-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=compensation
- `alpha://company/inmune-bio-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=governance
- `alpha://company/inmune-bio-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=shareholder-governance
- `alpha://company/inmune-bio-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=audit
- `alpha://company/inmune-bio-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=legal
- `alpha://company/inmune-bio-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=risk
- `alpha://company/inmune-bio-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=cyber
- `alpha://company/inmune-bio-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=ai-governance
- `alpha://company/inmune-bio-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=agents
- `alpha://company/inmune-bio-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=ecosystem
- `alpha://company/inmune-bio-inc/events` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=events
- `alpha://company/inmune-bio-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=relationships
- `alpha://company/inmune-bio-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=assessments
- `alpha://company/inmune-bio-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:marcia-allen","name":"Marcia Allen"},"source_id":"board_seats"}`
- Claim alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:timothy-schroeder","name":"Timothy Schroeder"},"source_id":"board_seats"}`
- Claim alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:timothy-schroeder","name":"Timothy Schroeder"},"source_id":"board_seats"}`
- Claim alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:j-kelly-ganjei","name":"J. Kelly Ganjei"},"source_id":"board_seats"}`
- Claim alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:marcia-allen","name":"Marcia Allen"},"source_id":"board_seats"}`
- Claim alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:j-kelly-ganjei","name":"J. Kelly Ganjei"},"source_id":"board_seats"}`

## Leadership

- David J. Moss: Director. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:5. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a.
- J. Kelly Ganjei: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:6. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a.
- Marcia Allen: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:7. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a.
- Scott Juda, J.D.: Director. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a.
- Timothy Schroeder: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:9. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a.
- Cory Ellspermann: Chief Financial Officer. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:10. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:38e353ee170527fb06612cfedc684cae6baa6465903d188efcb45e26837c3da3.
- David J. Moss: President, CEO, Secretary, Treasurer and Director. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:11. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6347c6e5b3b61ce18610386aa511593e480ddb8e6937a3682a1692e07ae29845.
- Mark Lowdell, PhD: Chief Scientific Officer. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:leadership_role:12. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6b8c92cf510113f7856db68394c4b64387a2eaa510f601ed7c861c784724190.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair not stated; Members Marcia Allen; Timothy Schroeder. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66.
- Compensation: Chair Timothy Schroeder; Members Timothy Schroeder (Chair); J. Kelly Ganjei. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66.
- Nominating and Governance: Chair Marcia Allen; Members Marcia Allen (Chair); J. Kelly Ganjei. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Inmune Bio, Inc.. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d47c1fa295c1513952cf8b5de033d8914539fe2866f6941c3c97a2055b47b74e.

## Entity Status

- Public listing published. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d47c1fa295c1513952cf8b5de033d8914539fe2866f6941c3c97a2055b47b74e.

## Published Fact

- US. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d47c1fa295c1513952cf8b5de033d8914539fe2866f6941c3c97a2055b47b74e.

## Committee Appointment

- Marcia Allen: member, Audit. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66.
- Timothy Schroeder: member, Audit. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66.
- Timothy Schroeder: chair, Compensation. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66.
- J. Kelly Ganjei: member, Compensation. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66.
- Marcia Allen: chair, Nominating and Governance. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66.
- J. Kelly Ganjei: member, Nominating and Governance. Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66.

## Security Listing

- INMB (NASDAQ). Claim: alpha:claim:company:a0f62a80-958f-46ca-b155-b220e0af379f:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d47c1fa295c1513952cf8b5de033d8914539fe2866f6941c3c97a2055b47b74e.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:d47c1fa295c1513952cf8b5de033d8914539fe2866f6941c3c97a2055b47b74e: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/inmune-bio-inc).
- alpha:projection-evidence:document:00d328082fb7f9b88374b3f78a9726031ee5111b2e97967b2859d5563f34663a: [Inmune Bio, Inc. DEF 14A 2026-04-23](https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm).
- alpha:projection-evidence:document:38e353ee170527fb06612cfedc684cae6baa6465903d188efcb45e26837c3da3: [INMB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm).
- alpha:projection-evidence:document:6347c6e5b3b61ce18610386aa511593e480ddb8e6937a3682a1692e07ae29845: [INMB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm).
- alpha:projection-evidence:document:f6b8c92cf510113f7856db68394c4b64387a2eaa510f601ed7c861c784724190: [INMB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm).
- alpha:projection-evidence:131c47341c2f06548dfaae470f6824eced4d1ba724cf8ed15a48220d5bcd3e66: [Audit](https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/inmune-bio-inc)
- [Public Markdown](https://registry.alpha.ac/companies/inmune-bio-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/inmune-bio-inc?format=jsonld)
- MCP resource: `alpha://companies/inmune-bio-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-21T09:39:51.203828+00:00; recorded 2026-10-21T09:39:51.203828+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.